Granulox
Oxygen, sprayed on.
When Granulox is sprayed onto a wound, highly purified haemoglobin binds oxygen from the surrounding air and diffuses through the wound exudate, supplying the wound base with oxygen. It is used alongside standard wound care for diabetic foot ulcers, venous, arterial and mixed leg ulcers, pressure ulcers and surgical wounds healing by secondary intention. It is applied at each dressing change, at least every three days, under an air-permeable dressing. A single 12 ml can is a portable, ready-to-use format for clinic and home care.
Key specifications
Why the Granulox
Oxygen through exudate
Exudate blocks most oxygen diffusion. Granulox haemoglobin binds oxygen from the air and carries it through the exudate layer to the wound base.
Fits the dressing routine
Sprayed on at each dressing change, at least every three days, then covered with the usual moist, air-permeable dressing.
Ready to use
A single 12 ml spray can, with no device, power or tubing, suits clinic, ward and home visits.
Know the precautions
Not for use in pregnancy, with occlusive films or hydrocolloids, or at the same time as locally acting medicines such as topical antibiotics. Rinse after antiseptics.
Where it is used
Diabetic foot and vascular clinics, community nursing, tissue viability services and long-term care, as an adjunct to standard wound care.
In the box
One Granulox 12 ml haemoglobin spray can with instructions for use. Pack sizes and configurations are confirmed with the quotation.
Clearance & compliance
CE marked medical device (class not verified) · listed on the UK NHS Drug Tariff Part IX. Supplied subject to registration in each destination country (MOHAP, DoH, DHA, SFDA or the equivalent authority). Certificates, declarations of conformity, IFUs and registration documents are provided with every quotation. Specifications are indicative and subject to manufacturer change.
Where a country has an official agent or authorised distributor, we source the item through it — or directly from the manufacturer if necessary. Product names, trademarks and images belong to their respective owners.
Questions
Is the Granulox available in the UAE and the GCC?
KGG sources Granulox on request for hospitals, wound clinics and home-care providers in the UAE, Saudi Arabia, Qatar, Kuwait, Bahrain and Oman, supplied subject to registration in each destination country. Availability is confirmed with each quotation.
How do I get a price?
Add it to your quote list or use Request a quote. We reply with pricing, lead time and the documents available for your country.
Is Granulox of animal origin?
Yes. Published product literature states that the haemoglobin is produced from porcine (pig) blood. Patients should be told before use, and it should not be used in people with hypersensitivity to its components or to animal proteins.
How often is it applied?
At each dressing change and at least every three days, sprayed evenly over the wound bed after cleansing, then covered with a moist, air-permeable dressing.
Which dressings can be used with it?
Moist, air-permeable dressings such as foams, superabsorbents and gelling fibres. Mölnlycke advises against occlusive plastic films and hydrocolloids.
Who owns Granulox now?
Mölnlycke Health Care. It was developed by SastoMed GmbH, which Mölnlycke acquired in 2018; earlier UK supply was through Infirst Healthcare.
Request a quote
Get pricing for the Granulox.
Tell us the quantity, delivery city and whether you are ordering for a facility, a team or a patient. We reply with pricing, lead time and the regulatory documents for your country.
English 
العربية